| Bioactivity | CP7-FP13-2 is a peptide with antivirulence factor and antibacterial activity. CP7-FP13-2 inhibits the formation of Staphylococcus aureus biofilm and has good antibacterial efficacy in mice[1]. |
| Name | CP7-FP13-2 |
| Sequence | Cyclo(-Leu-Leu-Phe-Ala-(Dab))-Asn-Ile-Gly-Gly-Cys-(6-Maleimidocaproic acid)-Gly-Ile-Lys-Asn-Leu-Trp-Lys-Lys-Met-Ile-Lys-Leu-Trp-Tyr |
| Shortening | Cyclo(LLFA-(Dab))-NIGGC-(6-Maleimidocaproic acid)-GIKNLWKKMIKLWY |
| Formula | C145H224N34O31S2 |
| Molar Mass | 3003.67 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lin H, et al. A Hybrid Antimicrobial Peptide Targeting Staphylococcus aureus with a Dual Function of Inhibiting Quorum Sensing Signaling and an Antibacterial Effect. J Med Chem. 2023 Dec 28;66(24):17105-17117. |